Recursion Pharmaceuticals is trading 5.2% up at $3.15 today, tracking a broader market rally as major indices gain more than 1%.
- The move comes amid a strong risk-on session in U.S. equities following easing geopolitical tensions and supportive macro headlines.
- There is no fresh, company-specific news or analyst action tied directly to the stock today.